Archifar

Archifar (Meropenem Anhydrous) is an intravenous antibiotic used to treat severe bacterial infections. This broad-spectrum medication is manufactured by Medochemie Ltd. and is available in the EU market.

Archifar is primarily used for the treatment of serious bacterial infections, including those affecting the skin, abdomen, and lungs. It is often prescribed for conditions where other antibiotics may not be effective. The medication works by stopping the growth of bacteria, helping the body to fight off infections.

Common effects of Archifar may include nausea, diarrhea, and headache. Some users might experience allergic reactions, such as rash or itching. It is important to monitor for any signs of adverse reactions and consult a healthcare provider if they occur.

Archifar should be used with caution in patients with a history of allergic reactions to antibiotics. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.

Archifar may interact with other medications, including certain antibiotics and antiepileptic drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be avoided while using this medication.